Robert Smith, MD, founder of Pathworks, will take over as medical director for the new lab, renamed EndoChoice Pathology, according to the report. Financial details of the transaction were not disclosed.
Read the Business Chronicle’s report about EndoChoice’s acquisition of Pathworks.